inositol has been researched along with Diabetic Angiopathies in 22 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mononeuritis (or mononeuritis multiplex) seems to be the result of ischaemia due to intrinsic or extrinsic (altered coagulability) vascular disease." | 2.37 | [Pathogenesis of diabetic neuropathies]. ( Arlot, S; Lalau, JD; Quichaud, J, 1985) |
| "Methylguanidine was only approximately 7% as effective as aminoguanidine as an inhibitor of AGE formation from L-lysine and G6P; both compounds were poor inhibitors of AR." | 1.29 | Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. ( Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, K | 1 |
| Satake, C | 1 |
| Izumi, T | 1 |
| Tanaka, M | 1 |
| Yamamoto, J | 1 |
| Asai, Y | 1 |
| Sawada, S | 1 |
| Imai, J | 1 |
| Yamada, T | 1 |
| Katagiri, H | 1 |
| Kaku, K | 1 |
| MENEGHINI, P | 1 |
| AVANZI, G | 1 |
| Lowe, WL | 1 |
| Florkiewicz, RZ | 1 |
| Yorek, MA | 1 |
| Spanheimer, RG | 1 |
| Albrecht, BN | 1 |
| Hacibekiroğlu, M | 1 |
| Akçay, T | 1 |
| Tilton, RG | 1 |
| Chang, K | 2 |
| Hasan, KS | 1 |
| Smith, SR | 1 |
| Petrash, JM | 1 |
| Misko, TP | 1 |
| Moore, WM | 1 |
| Currie, MG | 1 |
| Corbett, JA | 1 |
| McDaniel, ML | 1 |
| Bando, Y | 1 |
| Ushiogi, Y | 1 |
| Toya, D | 1 |
| Tanaka, N | 1 |
| Fujisawa, M | 1 |
| Daumerie-Goffinet, C | 1 |
| Lambert, AE | 1 |
| Clements, RS | 1 |
| Radhakrishnamurthy, B | 1 |
| Berenson, GS | 1 |
| Pargaonkar, PS | 1 |
| Voors, AW | 1 |
| Srinivasan, SR | 1 |
| Plavidal, F | 1 |
| Dolan, P | 1 |
| Dalferes, ER | 1 |
| Brownlee, M | 1 |
| Chakrabarti, S | 1 |
| Sima, AA | 1 |
| Hotta, N | 1 |
| Sano, T | 1 |
| Hasegawa, M | 1 |
| Inoue, M | 1 |
| Doi, K | 1 |
| Mio, R | 1 |
| Sumino, K | 1 |
| Fu, MX | 1 |
| Qian, RL | 1 |
| Sinclair, SH | 1 |
| Nesler, CL | 1 |
| Schwartz, SS | 1 |
| Winegrad, AI | 1 |
| Lalau, JD | 1 |
| Arlot, S | 1 |
| Quichaud, J | 1 |
| Williamson, JR | 1 |
| Rowold, E | 1 |
| Marvel, J | 1 |
| Tomlinson, M | 1 |
| Sherman, WR | 1 |
| Ackermann, KE | 1 |
| Kilo, C | 1 |
| Schwarz, D | 1 |
| Blasi, A | 2 |
| Licciardello, M | 2 |
5 reviews available for inositol and Diabetic Angiopathies
| Article | Year |
|---|---|
Efficacy of voglibose in type 2 diabetes.
Topics: Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucos | 2014 |
[Diabetic microangiopathies].
Topics: Basement Membrane; Blood Viscosity; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies | 1978 |
Biochemical derangements in diabetes mellitus.
Topics: Aorta; Basement Membrane; Blood Platelets; Blood Proteins; Carbohydrate Metabolism; Diabetes Mellitu | 1979 |
[Role of polyol-myoinositol metabolic changes in the pathogenesis of diabetic macro-angiopathy].
Topics: Animals; Diabetic Angiopathies; Humans; Inositol; Polymers | 1990 |
[Pathogenesis of diabetic neuropathies].
Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Energy Metabolism; Humans; | 1985 |
17 other studies available for inositol and Diabetic Angiopathies
| Article | Year |
|---|---|
Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Gl | 2019 |
[INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS].
Topics: Anticoagulants; Arteriosclerosis Obliterans; Arteritis; Coronary Disease; Diabetic Angiopathies; Eth | 1964 |
Regulation of growth factor mRNA levels in the eyes of diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Retino | 1995 |
The role of plasma, erythrocyte and platelet myo-inositol levels in the development of diabetic microangiopathy.
Topics: Adult; Blood Platelets; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic A | 1994 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; B | 1993 |
Three diabetic cases of acute dizziness due to initial administration of voglibose.
Topics: Aged; Aged, 80 and over; Cerebral Infarction; Cerebrovascular Circulation; Diabetes Mellitus, Type 2 | 1998 |
Serum-free and protein-bound sugars and cardiovascular complications in diabetes mellitus.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Blood Glucose; Blood Pressure; Cardiovascular Diseas | 1976 |
Glycosylation of proteins and microangiopathy.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diglycerides; Dogs; Gl | 1992 |
The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
Topics: Animals; Basement Membrane; Blood Glucose; Capillaries; Diabetes Mellitus, Type 1; Diabetic Angiopat | 1992 |
[Risk factors of developing diabetic complications].
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glycoprotei | 1991 |
[Clinical significance of serum myo-inositol analysis in the diabetic complications].
Topics: Animals; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gas Chromatography-Mass | 1990 |
Retinopathy in the pregnant diabetic.
Topics: Adult; Blood Flow Velocity; Diabetic Angiopathies; Diabetic Retinopathy; Enzymes; Female; Fluorescei | 1985 |
Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Ne | 1987 |
Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil.
Topics: Adolescent; Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Angiopathies; | 1986 |
[Medical therapy of obliterating arteriopathies].
Topics: Arteriosclerosis Obliterans; Diabetic Angiopathies; Gangrene; Humans; Inositol; Niacinamide; Pyridox | 1969 |
[Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Diabetic Angiopathies; Female; Humans; Inositol; Kallikrei | 1966 |
[Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Body Temperature; Diabetic Angiopathies; Female; Humans; I | 1966 |